Evaluation of action thresholds and spinosad for lepidopteran pest management in Minnesota cabbage.

Action thresholds, based on the percentage of plants infested, for the lepidopteran pest complex in fresh-market cabbage Brassica oleracea variety capitata were evaluated in 1996 and 1997 in southern Minnesota. Three lepidopteran pests are common in Minnesota, including the imported cabbageworm, Pieris (=Artogeia) rapae (L.), diamondback moth, Plutella xylostella (L.), and the cabbage looper, Trichoplusia ni (Hübner). Most of the thresholds tested included all three pests. However, because T. ni is often the most consistent and damaging pest in Minnesota, two thresholds were based solely on the percentage of plants infested with T. ni eggs and larvae. Action thresholds were also evaluated for their compatibility with a recently labeled biologically based insecticide, spinosad, and a conventional pyrethroid, permethrin. Although all three lepidopteran pests were present in both years of the study, P. rapae provided most of the pest pressure in 1996, and T. ni was most abundant in 1997. Compared with the 0% larval infestation treatment (approximately weekly sprays from early heading to harvest), all action thresholds resulted in less insecticide use (17- 80%), while maintaining high levels of marketability. Despite variable pest pressure between years, one of the thresholds based solely on T. ni (10% of plants infested with eggs or larvae) performed as well as each of the thresholds based on all three species combined. For both years, and compared with a weekly spray schedule from early heading to harvest (average of 5.5 sprays per year), use of the 10% T. ni egg or larval threshold resulted in an average of 36.5% (3.5 sprays) and 65% (2.0 sprays) fewer applications of spinosad and permethrin, respectively, with no significant loss in marketability. The results indicate that a variety of incidence-based action thresholds can be used to ensure the production of high-quality cabbage in the midwestern United States with only minimal applications of spinosad or permethrin.

Management of perioperative ventricular dysfunction.

With the recognition of the clinical importance of the right ventricle; the development of new techniques for the perioperative evaluation of RV function, particularly transesophageal echocardiography; and new treatment modalities (pharmacologic and mechanical), clinicians will be able to more accurately diagnose and precisely manage patients who have sustained RV injury.

Heparin management test versus activated coagulation time during cardiovascular surgery: correlation with anti-Xa activity.

OBJECTIVE: To compare the abilities of the heparin management test (HMT) and the activated coagulation time (ACT) to provide a measurement of heparin effect in patients undergoing cardiac or peripheral vascular surgery. These measurements of heparin effect were also compared with measurements of heparin concentrations tested by anti-Xa activity. A secondary objective was to compare the performance of the noncitrated HMT with that of the citrated HMT. DESIGN: A prospective study. SETTING: A single-center study conducted in a university hospital. PARTICIPANTS: After human investigation committee approval and informed consent were obtained, adult patients undergoing cardiac or peripheral vascular surgery were included in this study. INTERVENTIONS: In both surgical groups, blood was sampled for ACT, HMT, and anti-Xa activity. Each HMT was performed on both noncitrated and citrated samples. MEASUREMENTS AND MAIN RESULTS: As an indicator of heparin effect, the HMT had a strong correlation with the ACT (r = 0.899; p < 0.01). In addition, the HMT had a significantly stronger correlation with anti-Xa activity than the ACT (p < 0.01). The correlation obtained from the noncitrated samples was identical with that obtained from the citrated samples (r = 0.819; p < 0.001 for both groups). CONCLUSION: The ability of the HMT and the ACT to measure heparin effect was similar. The HMT performed better than the ACT when using anti-Xa activity as a measure of heparin concentration. Noncitrated HMT results were similar to citrated HMT results, thus supporting the use of fresh whole blood for testing purposes.

Point-of-care and standard laboratory coagulation testing during cardiovascular surgery: balancing reliability and timeliness.

OBJECTIVE: The use of point-of-care technology has increased faster than efforts to validate its effectiveness compared to standard laboratory testing modalities. To address this issue with a current point-of-care coagulation system (HEMOCHRON Jr, International Technidyne Corporation (ITC), Edison, NJ), we designed a study to test the hypothesis that data obtained from point-of-care coagulation equipment correlates with data obtained from standard laboratory coagulation equipment. One of the potential advantages gained using point-of-care testing is the ability to obtain more rapid results. To address this issue, turnaround time, defined as the elapsed time (in minutes) from when the sample was acquired from the patient until the investigators knew the results, was also determined. METHODS: Following Human Investigation Committee approval and informed consent, a prospective study was conducted to compare results obtained from point-of-care coagulation equipment with those results obtained from standard laboratory coagulation equipment. The study was performed in three groups of patients undergoing cardiovascular surgery, each requiring different levels of anticoagulation. RESULTS: Of the 83 patients who met the inclusion criteria, the correlation (combining data from groups 1-3) between results obtained from point-of-care and standard laboratory prothrombin time was r = 0.867, p < 0.001. The correlation (group 3) between point-of-care and standard laboratory international normalized ratio was r = 0.943, p < 0.001. The correlation (combining data from groups 1 & 2) between point-of-care and standard laboratory activated partial thromboplastin time was r = 0.825, p < 0.001. Median turnaround time for the standard laboratory was 90 minutes, with a mean turnaround time of 74 to 78 minutes, depending upon the group. In contrast, the median turnaround time for point-of-care testing was two minutes and 14 seconds. CONCLUSIONS: The results from this study population reveal that data obtained from point-of-care prothrombin time, international normalized ratio and activated partial thromboplastin time results correlate with results obtained from standard laboratory coagulation testing. The value of obtaining reliable results in a timely fashion offers a potential advantage for point-of-care testing in dinical situations, such as in the operating room, where saving time may translate into financial savings.

Is renal dose dopamine protective or therapeutic? Yes.

In conclusion, dopamine has the unique ability, compared with other catecholamines, to improve renal blood flow, glomerular filtration rate, sodium excretion, and creatinine clearance, independent of its cardiac effects. In addition, low-dose dopamine can decrease renal and systemic vascular resistance, suppress aldosterone secretion, and interact with atrial natriuretic factor. Because of these clinically significant properties, dopamine has been used successfully to improve and treat acute oliguric renal failure in a variety of clinical situations as just described. In addition, there were no adverse or toxic cardiac effects, such as tachyarrhythmias or hypertension, detected with low-dose dopamine in studies reviewed for this publication. By increasing renal and mesenteric vasodilation, dopamine has been shown to be beneficial in preserving renal function in cardiac surgery, vascular surgery, liver transplantation, contrast-induced nephropathy, hypertension, and pediatric patients. A therapeutic renal effect has been observed in patients with hepatorenal syndrome or severe ovarian hyperstimulation syndrome, in patients requiring vasopressors and IABP, and in selected cases of acute oliguric renal failure and shock. Furthermore, the combination of low-dose dopamine with furosemide or prostaglandin results in enhanced renal effects. Further investigation is necessary to evaluate the important and specific therapeutic role of low-dose dopamine through prospective, randomized, double-blind studies. Until those data are available, the plethora of clinical evidence supporting the ability of low-dose dopamine to augment renal function continues to grow. For those who are skeptical, we offer the following suggestion: "The obscure we see eventually, the obvious takes a little longer"--E.R. Murrow.

A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery.

Milrinone can reverse acute postischemic myocardial dysfunction after cardiopulmonary bypass, although neither the appropriate bolus dose nor its pharmacokinetics has been established for cardiac surgical patients. Consenting patients undergoing cardiac surgery received milrinone (25, 50, or 75 micrograms/kg) in an open-label, dose-escalating study if their cardiac index was < 3 L.min-1.m-2 after separation from bypass. Heart rate, mean arterial blood pressure, pulmonary capillary wedge pressure, and cardiac index were determined before and after the administration of milrinone. Timed blood samples were obtained for measurement of milrinone plasma concentrations and pharmacokinetic analysis. Twenty-nine of 60 consenting patients had cardiac indices < 3 L.min-1.m-2 after separation from bypass, received milrinone, and completed the protocol. All three bolus doses of milrinone significantly increased cardiac index. The 50- and 75-micrograms/kg doses produced significantly larger increases in cardiac index than the 25-micrograms/kg dose; however, the 75-micrograms/kg dose did not produce a significantly larger increase in cardiac index than did the 50-micrograms/kg dose. Two of 10 patients receiving milrinone 25 micrograms/kg, but no patient receiving either 50 or 75 micrograms/kg, required early epinephrine rescue when the cardiac index failed to increase by > 15%. The 75-micrograms/kg dose was associated with a case of ventricular tachycardia. The three-compartment model better described milrinone drug disposition than the two-compartment model by both visual inspection and Schwartz-Bayesian criterion. There was only limited evidence of dose-dependence, so data from all three doses are reported together (and normalized to the 50-micrograms/kg dose). Data from one patient was discarded (samples mislabeled). Using mixed-effects nonlinear regression (for n = 28), the following volumes were determined for the three compartments: V1 = 11.1 L, V2 = 16.9 L, and V3 = 363 L. Similarly, the following clearances were estimated for the three compartments: Cl1 = 0.067 L/min, Cl2 = 1.05 L/min, and Cl3 = 0.31 L/min. The 50-micrograms/kg loading dose appeared more potent than the 25-micrograms/kg dose, and, as potent, but with possibly fewer side-effects than the 75-micrograms/kg dose. The short context-sensitive half-times of 6.7 or 10.2 min after 1- or 10-min bolus infusions underscore the need for prompt institution of a maintenance infusion when milrinone concentrations must be maintained.(ABSTRACT TRUNCATED AT 400 WORDS)

The relationship between "normal" transesophageal color-flow Doppler-defined tricuspid regurgitation and thermodilution right ventricular ejection fraction measurements.

Twenty coronary artery revascularization patients, aged 58 +/- 15 years, were studied intraoperatively to define the impact of Doppler-defined tricuspid regurgitation on measurement of thermodilution right ventricular ejection fraction (50 msec response pulmonary artery catheter). Right ventricular function was also estimated using a measurement technique independent of flow patterns across the tricuspid valve (transesophageal two-dimensional echocardiographic 5.0 MHz phased-array transducer). Measurements included transverse plane long- and short-axis planimetered area ratio, respectively, and tricuspid annular plane systolic excursion ratio (ratio = end-diastolic minus end-systolic value divided by end-diastolic value). Data were expressed as thermodilution-echocardiographic gradients, ie, thermodilution ejection fraction minus long-axis planimetered area ratio, short-axis planimetered area ratio, and tricuspid annular plane systolic excursion ratio, respectively. Tricuspid regurgitation was quantified by color-flow Doppler perimetry of maximal regurgitation jet area and analysis of transduced right atrial pressure waveform. Doppler estimates were expressed as absolute values and as a function of corresponding atrial area (tricuspid regurgitation index = planimetered jet area divided by right atrial area). Data were obtained following endotracheal intubation, sternotomy, pericardiotomy, cardiopulmonary bypass, and chest closure. Data were evaluated by regression analysis, with separate analyses performed for each time period. Profiles were unassociated with right atrial pressure waveform abnormalities. There was no significant relationship between thermodilution ejection fraction variance values and tricuspid regurgitation jet area or regurgitation index, respectively. In each measurement period, thermodilution-echocardiographic gradients were also unrelated to the tricuspid regurgitation estimates.(ABSTRACT TRUNCATED AT 250 WORDS)

Pulmonary artery catheters: what's the controversy?

Controversy surrounding the use or misuse of the pulmonary artery catheter (PAC) remains one of the most frequently debated issues in anesthesia, critical care, and cardiology. It has been argued that the cardiovascular data it provides, its ease of insertion, and the low incidence of associated complications mandate its use in all patients undergoing cardiac surgery. Conversely, it has been suggested that clinical experience, combined with information derived from the central venous pressure (CVP) and noninvasive monitors, is adequate to diagnose and treat hemodynamic abnormalities in the perioperative period. A retrospective study addressing the specific issue of patient outcome showed a significant reduction in perioperative reinfarction rates in patients with coronary artery disease undergoing noncardiac surgery compared with historical controls. In another study of patients with left main coronary artery disease undergoing coronary artery bypass grafting (CABG), mortality was decreased from 20.0% to 3.5% in the group monitored with a PAC. In patients undergoing cardiac surgery, data derived from the PAC were shown to be a more sensitive indicator of hemodynamic abnormalities than were "routine" parameters. A definitive assessment of the usefulness of the PAC awaits further investigation.

Transesophageal echocardiography: is it for everyone?

Intraoperative use of transesophageal echocardiography (TEE) to detect ischemia is more predictive of a postoperative myocardial infarction than is ECG, and two-dimensional (2-D) TEE has been shown to be more sensitive than ECG in detecting regional wall-motion abnormalities, which are highly suggestive of ischemia. More recent studies have demonstrated that postbypass TEE ischemia is predictive of an adverse outcome. Other potential diagnostic uses of TEE include evaluation and identification of intraoperative ventricular aneurysms and assessment of papillary muscle function. Intraoperative detection of thrombus and atrial myxoma has been significantly enhanced using 2-D TEE and, in the postoperative period, TEE is a more sensitive measure of pericardial tamponade than changes in hemodynamic variables. In cardiac surgery, contrast TEE has been reported to be useful in evaluating the adequacy of the delivery of cardioplegia as well as aiding in the detection of air emboli. The incorporation of Doppler into TEE probes now enhances the clinician's ability to diagnose and treat patients with valvular heart disease. The value of TEE must be weighed against cost-effectiveness and outcome as it becomes more widely used.

Management of acute right ventricular failure.

The thin-walled right ventricle compensates poorly for any increase in afterload, and its output abruptly decreases with small elevations in pulmonary vascular resistance. In patients who have acute right ventricular (RV) dysfunction following bypass, it is, therefore, important to maintain pulmonary vascular resistance at normal or reduced levels. The location and movement of the RV septum may have a dramatic impact on RV contraction, and abnormalities of left ventricular function all affect RV function. Inadequate intraoperative protection has also been implicated in impaired RV function, and there is some evidence that caution is required during removal of air from the left side of the heart and resumption of ventilation. Volume expansion, pharmacological intervention, and mechanical devices have all been used successfully in patients with RV failure. Volume loading is the basis of treatment when the pulmonary vascular resistance is normal. When this alone is insufficient, or when pulmonary vascular resistance is elevated, inotropic agents may be useful. Clinical reports have demonstrated that amrinone, a member of the new class of inotropic fraction-III phosphodiesterase inhibitors, is an effective agent for the management of RV dysfunction following bypass. Correction of septal wall dislocation may be achieved with intraaortic balloon pumps.

The effect of incremental positive end-expiratory pressure on right ventricular hemodynamics and ejection fraction.

The effects of incremental positive end-expiratory pressure (PEEP) on right ventricular (RV) function were evaluated in 36 (n = 36) ventilated patients. Positive end-expiratory pressure was increased from 0 (baseline) to 20 cm H2O in 5-cm H2O increments and RV hemodynamics and thermally derived right ventricular ejection fraction (RVEF), right ventricular end-diastolic volume index (RVEDVI), and right ventricular end-systolic volume index (RVESVI) were computed. Right ventricular contractility was determined from the analysis of RV systolic pressure-volume relations. Right ventricular ejection fraction declined from 42 +/- 8% at baseline to 30 +/- 9% at 20 cm H2O PEEP. Right ventricular end-diastolic volume index declined between 0 and 5 cm H2O PEEP (103 +/- 42 to 92 +/- 34 ml.m-2) and then increased to 113 +/- 40 at 20 cm H2O PEEP. Right ventricular end-systolic volume index increased from 60 +/- 31 ml.m-2 at baseline to 79 +/- 34 ml.m-2 at 20 cm H2O PEEP. The slope (E) of the relation of RV peak systolic pressure to RV end-systolic volume index decreased from 0.26 mm Hg.m2.ml-1 between PEEP of 0-15 cm H2O to 0.05 mm Hg.m2.m-1 at PEEP greater than 15 cm H2O. It is concluded that low levels of PEEP have a predominant preload reducing effect on the RV. Above 15 cm H2O PEEP, RV volumes increase and E decreases, consistent with increased RV afterload and a decline in RV contractility.

Protamine: does it alter right ventricular function?

Protamine administration has been associated with cardiac decompensation secondary to acute pulmonary vasoconstriction and subsequent right ventricular failure. To determine whether protamine infusion produced alterations in right ventricular performance, we evaluated both right and left ventricular function in patients receiving protamine infusion. The dose of protamine administered was calculated as adequate to reverse heparin as measured by the activated clotting time (ACT). Indices of right and left ventricular function obtained included right atrial pressure, right ventricular pressure, right ventricular ejection fraction, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac output, blood pressure, and heart rate. These measurements were obtained prior to protamine administration, at 1/2 total protamine dose, at completion of protamine infusion, and prior to sternal closure. No significant changes in right ventricular ejection fraction, right ventricular end-diastolic pressure, mean pulmonary artery pressure, or pulmonary vascular resistance were seen at any point during the study. Left ventricular function remained unchanged. Even in patients who are possibly at an increased risk (pulmonary artery hypertension, PAP greater than 25 mm Hg), no deterioration in right or left ventricular function could be demonstrated following protamine administration. These data suggest that protamine does not consistently exert a significant detrimental effect on right ventricular performance.

The adult respiratory distress syndrome.

The adult respiratory distress syndrome (ARDS) represents a common denominator of acute lung injury leading to alveolar flooding, decreased lung compliance, and altered gas transport. In the absence of specific etiology and therapy, the management of ARDS remains largely supportive. Ubiquitous use of intermittent positive-pressure ventilation with positive end-expiratory pressure (PEEP) improves arterial oxygenation but with some risk of pulmonary barotrauma and decreased cardiac output. The recent understanding of lung inflation as a modulator of right heart afterload and the effect of the right ventricle on global cardiac performance continues to redefine optimal patterns of ventilatory and hemodynamic intervention in ARDS.